Table 1 (Abstract 17) Summary of real-world outcomes of patients with melanoma brain metastasis in the German ADOReg skin cancer registry. This Table 1 belongs to Abstract 17
From: Immunotherapy Bridge 2020 and Melanoma Bridge 2020: meeting abstracts
|
No melanoma brain metastases N = 500 | Any melanoma brain metastases | |||
|---|---|---|---|---|
|
At least one melanoma brain metastasis N = 164 |
Single melanoma brain metastasis N = 46 |
Two or more melanoma brain metastases N = 106 | ||
| Survival rate at 24 months, % | 58.9% | 45.7% | 58.7% | 40.0% |
| Median OS in months (95% CI) | 32.8 (27.6–39.8) | 19.6 (13.7—30.3) | 47.2 (16.0—NR) | 16.7 (10.4 – 25.1) |
| Median rwToT in months (95% CI) | 6.3 (5.3 – 7.2) | 6.0 (4.1 – 6.9) | 6.5 (3.1 – 12.5) | 5.1 (3–5 7.2) |